SARS-CoV-2 - Comirnaty, Spikevax (Approved http://www.fda.gov/) and numerous candidates in clinical trials (reviewed in (13))Influenza (NCT05052697)HIV (NCT05001373)Zika (NCT04917861)Tuberculosis (NCT05537038)Chikungunya virus (NCT03829384)Anti-claudin 18.2 antibody (NCT04683939)Interleukin-2 (NCT04455620)Vascular endothelial growth factor A (NCT03370887)Propionic acidemia (NCT04159103)Methylmalonic acidemia (NCT04899310)Glycogen storage disease 1a (NCT05095727). This evidence concerns the gene CLDN18 and propionic acidemia.